BHV-3241 in Subjects with Multiple System Atrophy Home / Patient Care / Take Action / Find a Clinical Trial / Clinical Trials / BHV-3241 in Subjects with Multiple System Atrophy The purpose of this study is to compare the efficacy of BHV-3241 versus placebo in subjects with multiple system atrophy. Status Open and enrolling subjects. Location Phoenix, Arizona Age Range 40-75 Total Participants 250 Keywords multiple system atrophy Parkinson's disease Primary Sponsor Biohaven Pharmaceuticals, Inc. Muhammad Ali Parkinson Center Muhammad Ali Parkinson Center Muhammad Ali Parkinson Center Call Us Enrollment Information Call 1-877-287-7122 Call Us
